Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Nandrolone furylpropionate
Другие языки:

    Nandrolone furylpropionate

    Подписчиков: 0, рейтинг: 0
    Nandrolone furylpropionate
    Nandrolonefurylpropionate structure.png
    Clinical data
    Trade names Demelon
    Other names NFP; Nandrolone 17β-furylpropionate; 19-Nortestosterone 17β-(2-furanyl)propanoate
    Routes of
    administration
    Intramuscular injection
    Drug class Androgen; Anabolic steroid; Androgen ester; Progestogen
    Identifiers
    • [(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] 3-(furan-2-yl)propanoate
    CAS Number
    PubChem CID
    ChemSpider
    UNII
    CompTox Dashboard (EPA)
    ECHA InfoCard 100.028.709
    Chemical and physical data
    Formula C25H32O4
    Molar mass 396.527 g·mol−1
    3D model (JSmol)
    • C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4=CC=CO4)CCC5=CC(=O)CC[C@H]35
    • InChI=1S/C25H32O4/c1-25-13-12-20-19-8-5-17(26)15-16(19)4-7-21(20)22(25)9-10-23(25)29-24(27)11-6-18-3-2-14-28-18/h2-3,14-15,19-23H,4-13H2,1H3/t19-,20+,21+,22-,23-,25-/m0/s1
    • Key:ICNIVTHKZKRHPD-YNFNDHOQSA-N

    Nandrolone furylpropionate (NFP) (JAN) (brand name Demelon), also known as 19-nortestosterone 17β-(2-furanyl)propanoate, is a synthetic androgen and anabolic steroid and a nandrolone ester. It was developed and marketed by Mochida Pharmaceutical in Japan in the 1960s.

    Relative affinities (%) of nandrolone and related steroids
    Compound PR AR ER GR MR SHBG CBG
    Nandrolone 20 154–155 <0.1 0.5 1.6 1–16 0.1
    Testosterone 1.0–1.2 100 <0.1 0.17 0.9 19–82 3–8
    Estradiol 2.6 7.9 100 0.6 0.13 8.7–12 <0.1
    Notes: Values are percentages (%). Reference ligands (100%) were progesterone for the PR, testosterone for the AR, estradiol for the ER, dexamethasone for the GR, aldosterone for the MR, dihydrotestosterone for SHBG, and cortisol for CBG. Sources: See template.

    See also




    Новое сообщение